Intrust Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.76M | Buy |
29,053
+3,645
| +14% | +$212K | 0.14% | 116 |
|
|
2025
Q4 | $1.37M | Buy |
25,408
+2,946
| +13% | +$142K | 0.11% | 130 |
|
|
2025
Q3 | $1.01M | Sell |
22,462
-1,289
| -5% | -$60.2K | 0.08% | 164 |
|
|
2025
Q2 | $1.1M | Sell |
23,751
-10,731
| -31% | -$527K | 0.1% | 146 |
|
|
2025
Q1 | $2.1M | Buy |
34,482
+2,691
| +8% | +$157K | 0.21% | 88 |
|
|
2024
Q4 | $1.8M | Buy |
31,791
+8,894
| +39% | +$497K | 0.18% | 99 |
|
|
2024
Q3 | $1.18M | Buy |
22,897
+3,112
| +16% | +$146K | 0.12% | 135 |
|
|
2024
Q2 | $822K | Sell |
19,785
-4,419
| -18% | -$198K | 0.09% | 172 |
|
|
2024
Q1 | $1.31M | Buy |
24,204
+2,284
| +10% | +$116K | 0.14% | 123 |
|
|
2023
Q4 | $1.12M | Sell |
21,920
-1,611
| -7% | -$84.6K | 0.13% | 137 |
|
|
2023
Q3 | $1.37M | Sell |
23,531
-2,645
| -10% | -$162K | 0.17% | 106 |
|
|
2023
Q2 | $1.67M | Sell |
26,176
-3,752
| -13% | -$252K | 0.2% | 93 |
|
|
2023
Q1 | $2.07M | Sell |
29,928
-852
| -3% | -$60.1K | 0.27% | 69 |
|
|
2022
Q4 | $2.21M | Buy |
30,780
+76
| +0.2% | +$5.73K | 0.31% | 57 |
|
|
2022
Q3 | $2.18M | Sell |
30,704
-3,673
| -11% | -$266K | 0.34% | 51 |
|
|
2022
Q2 | $2.65M | Buy |
34,377
+3,092
| +10% | +$235K | 0.38% | 45 |
|
|
2022
Q1 | $2.29M | Buy |
31,285
+8,592
| +38% | +$577K | 0.29% | 63 |
|
|
2021
Q4 | $1.42M | Buy |
22,693
+288
| +1% | +$16.9K | 0.17% | 109 |
|
|
2021
Q3 | $1.33M | Sell |
22,405
-1,464
| -6% | -$96.4K | 0.18% | 111 |
|
|
2021
Q2 | $1.59M | Sell |
23,869
-947
| -4% | -$61.8K | 0.22% | 93 |
|
|
2021
Q1 | $1.57M | Sell |
24,816
-4,488
| -15% | -$279K | 0.23% | 88 |
|
|
2020
Q4 | $1.82M | Sell |
29,304
-1,116
| -4% | -$68.6K | 0.28% | 74 |
|
|
2020
Q3 | $1.83M | Sell |
30,420
-220
| -0.7% | -$13.2K | 0.33% | 66 |
|
|
2020
Q2 | $1.8M | Buy |
30,640
+1,637
| +6% | +$97.9K | 0.36% | 62 |
|
|
2020
Q1 | $1.62M | Buy |
29,003
+2,262
| +8% | +$138K | 0.45% | 51 |
|
|
2019
Q4 | $1.72M | Buy |
26,741
+8,041
| +43% | +$461K | 0.39% | 58 |
|
|
2019
Q3 | $948K | Buy |
18,700
+226
| +1% | +$10.6K | 0.24% | 102 |
|
|
2019
Q2 | $838K | Buy |
18,474
+1,943
| +12% | +$90.5K | 0.2% | 125 |
|
|
2019
Q1 | $789K | Sell |
16,531
-1,556
| -9% | -$77.5K | 0.2% | 131 |
|
|
2018
Q4 | $940K | Buy |
18,087
+1,502
| +9% | +$80.7K | 0.27% | 83 |
|
|
2018
Q3 | $1.03M | Buy |
16,585
+13
| +0.1% | +$771 | 0.26% | 90 |
|
|
2018
Q2 | $918K | Sell |
16,572
-2,136
| -11% | -$115K | 0.25% | 98 |
|
|
2018
Q1 | $1.18M | Sell |
18,708
-378
| -2% | -$24.3K | 0.34% | 70 |
|
|
2017
Q4 | $1.17M | Sell |
19,086
-577
| -3% | -$36.1K | 0.35% | 72 |
|
|
2017
Q3 | $1.25M | Buy |
19,663
+42
| +0.2% | +$2.45K | 0.41% | 64 |
|
|
2017
Q2 | $1.09M | Buy |
19,621
+9
| +0% | +$490 | 0.37% | 73 |
|
|
2017
Q1 | $1.07M | Sell |
19,612
-52
| -0.3% | -$2.85K | 0.38% | 66 |
|
|
2016
Q4 | $1.15M | Sell |
19,664
-1,569
| -7% | -$85.8K | 0.44% | 50 |
|
|
2016
Q3 | $1.15M | Buy |
21,233
+2,061
| +11% | +$132K | 0.46% | 50 |
|
|
2016
Q2 | $1.41M | Sell |
19,172
-2,397
| -11% | -$169K | 0.57% | 38 |
|
|
2016
Q1 | $1.38M | Buy |
21,569
+5,932
| +38% | +$374K | 0.49% | 65 |
|
|
2015
Q4 | $1.07M | Sell |
15,637
-58
| -0.4% | -$3.83K | 0.4% | 84 |
|
|
2015
Q3 | $929K | Buy |
15,695
+720
| +5% | +$45.7K | 0.35% | 92 |
|
|
2015
Q2 | $996K | Buy |
14,975
+1,459
| +11% | +$96.2K | 0.35% | 92 |
|
|
2015
Q1 | $872K | Sell |
13,516
-724
| -5% | -$45.3K | 0.31% | 101 |
|
|
2014
Q4 | $841K | Sell |
14,240
-2,106
| -13% | -$119K | 0.31% | 100 |
|
|
2014
Q3 | $836K | Sell |
16,346
-658
| -4% | -$32.9K | 0.32% | 92 |
|
|
2014
Q2 | $825K | Sell |
17,004
-2,093
| -11% | -$103K | 0.31% | 90 |
|
|
2014
Q1 | $992K | Buy |
19,097
+4,104
| +27% | +$218K | 0.41% | 69 |
|
|
2013
Q4 | $797K | Sell |
14,993
-967
| -6% | -$49.3K | 0.35% | 85 |
|
|
2013
Q3 | $739K | Sell |
15,960
-7,270
| -31% | -$319K | 0.36% | 88 |
|
|
2013
Q2 | $1.04M | Buy |
+23,230
| New | +$1.01M | 0.46% | 57 |
|
Other funds holding BMY
VCM
VPM
Intrust Bank's BMY Position: Q1 2026 in Review
Intrust Bank increased its Bristol-Myers Squibb (BMY) stake by 14% in Q1 2026, buying an estimated $212K and bringing the position to 29,053 shares worth $1.76M. The position accounts for 0.14% of the portfolio, ranked #116.
Intrust Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.65M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Intrust Bank held 29,053 shares of Bristol-Myers Squibb worth $1.76M as of Q1 2026.
- Intrust Bank bought 3,645 Bristol-Myers Squibb shares in Q1 2026, an estimated $212K.
- Bristol-Myers Squibb made up 0.14% of Intrust Bank's portfolio in Q1 2026, its #116 holding.
- Intrust Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Intrust Bank's Bristol-Myers Squibb position peaked at $2.65M in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.